We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.71 | 0.56% | 128.00 | 21,303 | 09:55:00 |
FRANKFURT--The following is a summary of analysts' forecasts for Novo Nordisk A/S (NVO) second-quarter results, based on a poll of six analysts conducted by Dow Jones Newswires (figures in million danish kroner, EPS, dividend and target price in danish kroner, according to IFRS). Earnings figures are scheduled to be released August 6.
=== Sales: -NovoRapid/ 2nd Quarter -Total -Victoza -Levemir NovoLog AVERAGE 27,161 4,109 4,782 5,258 Prev. Year 21,629 3,059 3,618 4,251 +/- in % +26 +34 +32 +24 MEDIAN 27,280 4,097 4,801 5,244 Maximum 27,676 4,190 5,083 5,310 Minimum 26,554 4,034 4,428 5,228 Amount 6 5 5 5 Baader-Helvea 27,151 4,190 5,083 5,242 Credit Suisse 27,472 -- -- -- Deutsche Bank 27,676 4,097 4,801 5,310 Jefferies 26,704 4,081 4,679 5,244 Morgan Stanley 26,554 4,034 4,428 5,267 Swedbank 27,408 4,145 4,920 5,228 Operating Net EPS 2nd Quarter profit PBT income diluted AVERAGE 11,818 10,288 8,090 3.13 Prev. Year 8,733 8,989 6,994 2.66 +/- in % +35 +14 +16 +18 MEDIAN 11,699 10,046 7,947 3.08 Maximum 12,625 11,189 8,740 3.41 Minimum 11,048 9,526 7,525 2.91 Amount 6 5 5 5 Baader-Helvea 11,418 10,046 7,947 3.08 Credit Suisse 11,871 -- -- -- Deutsche Bank 12,625 11,189 8,740 3.41 Jefferies 11,526 9,526 7,525 2.91 Morgan Stanley 11,048 9,848 7,682 2.96 Swedbank 12,422 10,830 8,556 3.29 Target price Rating DPS 2015 AVERAGE 413.20 positive 3 AVERAGE 6.23 neutral 2 Prev. Year 5.00 negative 0 +/- in % +25 MEDIAN 425.00 Maximum 450.00 Minimum 345.00 Amount 5 Amount 3 Baader-Helvea 411.00 Buy -- Deutsche Bank 345.00 Hold 6.75 Jefferies 425.00 Hold 6.34 Morgan Stanley 435.00 Overweight -- Swedbank 450.00 Buy 5.60 ===
Year-earlier figures are as reported by the company.
DJG/mus
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novo Nordisk Chart |
1 Month Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions